Features of the management of patients with exacerbation of atopic dermatitis against the background of pregnancy


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective: to evaluate the effecacy, safety and tolerability of a series of Neotanine preparations in pregnant women with exacerbation of atopic dermatitis (AD). Methods. 21 pregnant women with exacerbation of AD at the age of 20 to 40 years were examined at the gestation age of 8 to 30 weeks. The diagnosis was confirmed based on data of medical history and clinical picture of the disease. The examination was carried out 5 times for 14-16 days, therapy was prescribed by 2 stages. At the first stage (1-5 days), Neotanine spray or lotion (suspension) was prescribed 3-4 times a day until the elements were completely dried. At this stage, the patients were divided into 2 groups. Patients of the first group (11 persons) were prescribed Neotanine lotion; the use of Neotanine spray was recommended for patients of the second group (10 persons). At the second stage, all patients were prescribed Neotanine cream until the disappearance of the skin manifestations. Results. After the therapy, almost all patients managed to achieve positive results. Conclusion. The results of this study allow to recommend the Neotanin preparations as a safe and effective means that can be used in the treatment of pregnant women suffering from AD.

Толық мәтін

Рұқсат жабық

Авторлар туралы

K. Monakhov

Pavlov First Saint Petersburg State Medical University

Department of Dermatovenerology with the Clinic

N. Kholodilova

Pavlov First Saint Petersburg State Medical University

Email: cholnatalex23@rambler.ru
PhD, Teaching Assistant at the Department of Dermatovenereology with the Clinic

Әдебиет тізімі

  1. Соколовский Е.В., Монахов К.Н., Холодилова Н.А. Опыт применения 0,1%-ной мази мометазона фуроата у беременных, больных экземой кистей. Соврем. проблемы дерматовенерологии, иммунологии и врачебной косметологии. 2014;VIII-IX,1 (29):20-3.
  2. Päunescu M.M., Feier V., Päunescu M., et al. Dermatoses of pregnancy. Acta Dermatovenerol. Alp. Panonica. Adriat. 2008;17(1):4-11.
  3. Монахов К.Н., Холодилова Н.А. Опыт применения лоратадина у беременных с зудящими дерматозами. Вестн. дерматологии и венерологии. 2016;(3):123-27.
  4. Kemmett D., Tidman M.J. The influence of menstrual cycle and pregnancy on atopic dermatitis. Br. J. Dermatol. 1991; 125(1):59-61.
  5. Vaughan Jones S.A., Hern S., Nelson-Piercy C., et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br. J. Dermatol. 1999;141(1):71-81.
  6. Каширская Е.Н. Атопический дерматит и беременность (Особенности клиники, гормонально-метаболической перестройки, тактика ведения беременных как первичная профилактика атопического дерматита у детей). Дисс. канд. мед. наук. Екатеринбург, 1998.
  7. Кочергин Н.Г Особенности кожной патологии при беременности. Росс. журн. кожных и венерических болезней. 2002;1:33-6.
  8. Клиническая аллергология и иммунология. Руководство для практикующих врачей / Под ред. Л.А. Горячкиной, К.П. Кашкина. М., 2011. 432 с.
  9. Wojnarowska F. The skin in pregnancy. Oxford textbook of medicine: Fourth edition. ed. By D.A. Warell, et al. New York: Oxford Universisity Press, 2006;1.
  10. Müller C., Hausen B. Contact allergy to a synthetic tannin in Tannosynt liquid. Contact Dermatitis 1994;31:185.
  11. Fölster-Holst R. Indications for tannin therapy in dermatology. European Society for Pediatric Dermatology 8th Congress, Budapest, 2005:31-2.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>